ACADIA Pharmaceuticals Inc. news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

ACAD 32.98 +0.13 (0.41%)
price chart
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
SAN DIEGO, Nov 25, 2014 (BUSINESS WIRE) -- ACADIA Pharmaceuticals Inc. ACAD, +4.27% a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, ...
Related articles »  
This Is A Good Time To Buy Acadia Pharmaceuticals (ACAD)
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) is in the process of a filing a new drug application (NDA) for Nuplazid (pimavanserin), which is a first-in-class treatment for Parkinson's disease psychosis, or PDP.
Related articles »  
Newfield Exploration Co. (NFX), ACADIA Pharmaceuticals Inc. (ACAD): How Did ...
Andreas Halvorsen's Viking Global is a fund with great returns over its 15-years old history. Since its foundation, Viking's flagship fund returned on average 19% per year.
Related articles »  
Company High Short Interest: Acadia Pharmaceuticals Inc , Vringo Inc
Acadia Pharmaceuticals Inc (NASDAQ:ACAD) is in a strong bear grip; the short interest is registered high at 29.45% of the floated shares.
Company Operations Updates: Colfax Corp , Acadia Pharmaceuticals Inc  The Daily Joplin
Related articles »  
Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme ...
ACADIA Pharmaceuticals Inc.'s shares have surged 18.65% in the last one month and 18.78% in the previous three months. Additionally, the stock has gained 30.57% on YTD basis.
Related articles »  
Company Price Targets: Acadia Pharmaceuticals Inc , Republic Services
Acadia Pharmaceuticals Inc (NASDAQ:ACAD): According to 6 Analysts, The short term target price has been estimated at $ 38.The target price could deviate by a maximum of $7.51 from the forecast price.
Stocks Roundup:MFA Financial, (NYSE:MFA), ACADIA Pharmaceuticals ...  Techsonian (press release)
Related articles »  
ACADIA Pharmaceuticals Coverage Initiated at Cowen and Company (ACAD)
ACADIA Pharmaceuticals Inc. logo Cowen and Company began coverage on shares of ACADIA Pharmaceuticals (NASDAQ:ACAD) in a report released on Friday, TheFlyOnTheWall.
Company High Short Interest:Acadia Pharmaceuticals Inc , M/I Homes  Markets Insider
Related articles »  
Companies receive Brokerage Rating: Acadia Pharmaceuticals Inc , Radioshack ...
Research firm Zacks has rated Acadia Pharmaceuticals Inc (NASDAQ:ACAD) and has ranked it at 3, indicating that its shares are a Neutral.
Disclosure on High Short Interest: Acadia Pharmaceuticals Inc , Radioshack Corp  Markets Insider
Related articles »  
Tuesday Watch List: ACADIA Pharmaceuticals Inc. (ACAD), Equity Residential ...
ACADIA Pharmaceuticals Inc. (ACAD) during the last trading day closed at $30.34, a loss of -6.73% trading at a volume of 2243965 shares.
Shares Surging to New 52 Week High: Acadia Pharmaceuticals Inc , Esperion ...
Acadia Pharmaceuticals Inc (NASDAQ:ACAD) is having a phenomenal day in the stock market, with its shares touching a new yearly high of $32.72.
ACADIA Pharmaceuticals Hits New 1-Year High at $32.72 (ACAD)  Watch List News (press release)
Related articles »